Keith Goldan
Direttore Finanziario/CFO presso SYNDAX PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 30/06/2024
Posizioni attive di Keith Goldan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05/05/2023 | - |
| Direttore Finanziario/CFO | 13/06/2022 | - | |
| Treasurer | 13/06/2022 | - |
Storia della carriera di Keith Goldan
Precedenti posizioni note di Keith Goldan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OPTINOSE, INC. | Direttore Finanziario/CFO | 01/01/2017 | 10/06/2022 |
| FIBROCELL SCIENCE, INC. | Direttore Finanziario/CFO | 18/03/2015 | 01/01/2017 |
| Segretario Aziendale | 18/03/2015 | 17/06/2015 | |
| Treasurer | 18/03/2015 | 01/01/2017 | |
| NUPATHE INC | Direttore Finanziario/CFO | 04/05/2009 | 21/02/2014 |
| Contatto Relazioni con gli Investitori | 22/03/2011 | 21/02/2014 | |
| Public Communications Contact | 15/02/2011 | 21/02/2014 | |
Cantel Medical (UK) Ltd.
 Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Direttore Finanziario/CFO | - | 31/10/2008 |
| REALM THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/10/2004 | 13/10/2008 |
| Direttore Finanziario/CFO | 01/10/2004 | 13/10/2008 | |
| Century Capital Associates | Fondatore | - | - |
| Membro del Comitato di Investimento | - | 21/06/2011 | |
| Corporate Officer/Principal | - | - | |
Biosyn, Inc.
 Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Direttore Finanziario/CFO | - | - |
Formazione di Keith Goldan
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Robert H. Smith School of Business | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 7 |
| Treasurer | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Retail Trade |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Biosyn, Inc.
Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
| Century Capital Associates | |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. | Health Technology |
- Borsa valori
- Insiders
- Keith Goldan
- Esperienza
